BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 9010920)

  • 1. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men.
    Schirra J; Kuwert P; Wank U; Leicht P; Arnold R; Göke B; Katschinski M
    Proc Assoc Am Physicians; 1997 Jan; 109(1):84-97. PubMed ID: 9010920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
    Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.
    Schirra J; Leicht P; Hildebrand P; Beglinger C; Arnold R; Göke B; Katschinski M
    J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
    Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
    J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.
    Frost GS; Brynes AE; Dhillo WS; Bloom SR; McBurney MI
    Eur J Clin Nutr; 2003 Feb; 57(2):293-8. PubMed ID: 12571662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
    Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
    Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitric oxide on antral motility and gastric emptying in humans.
    Konturek JW; Thor P; Domschke W
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):97-102. PubMed ID: 7712314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans.
    Meier JJ; Nauck MA; Pott A; Heinze K; Goetze O; Bulut K; Schmidt WE; Gallwitz B; Holst JJ
    Gastroenterology; 2006 Jan; 130(1):44-54. PubMed ID: 16401467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.
    Nauck MA; Wollschläger D; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Willms B
    Diabetologia; 1996 Dec; 39(12):1546-53. PubMed ID: 8960841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clonidine and sumatriptan on postprandial gastric volume response, antral contraction waves and emptying: an MRI study.
    Kwiatek MA; Fox MR; Steingoetter A; Menne D; Pal A; Fruehauf H; Kaufman E; Forras-Kaufman Z; Brasseur JG; Goetze O; Hebbard GS; Boesiger P; Thumshirn M; Fried M; Schwizer W
    Neurogastroenterol Motil; 2009 Sep; 21(9):928-e71. PubMed ID: 19413683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gastrointestinal hormones in postprandial reduction of bone resorption.
    Henriksen DB; Alexandersen P; Bjarnason NH; Vilsbøll T; Hartmann B; Henriksen EE; Byrjalsen I; Krarup T; Holst JJ; Christiansen C
    J Bone Miner Res; 2003 Dec; 18(12):2180-9. PubMed ID: 14672353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men.
    Pilichiewicz AN; Chaikomin R; Brennan IM; Wishart JM; Rayner CK; Jones KL; Smout AJ; Horowitz M; Feinle-Bisset C
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E743-53. PubMed ID: 17609258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans.
    Schirra J; Houck P; Wank U; Arnold R; Göke B; Katschinski M
    Gut; 2000 May; 46(5):622-31. PubMed ID: 10764704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs.
    Nagell CF; Wettergren A; Ørskov C; Holst JJ
    Scand J Gastroenterol; 2006 Jun; 41(6):667-72. PubMed ID: 16716964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes.
    Heptulla RA; Rodriguez LM; Mason KJ; Haymond MW
    Pediatr Diabetes; 2008 Dec; 9(6):561-6. PubMed ID: 18761650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 regulates gastroduodenal motility involving cholinergic pathways.
    Schirra J; Nicolaus M; Woerle HJ; Struckmeier C; Katschinski M; Göke B
    Neurogastroenterol Motil; 2009 Jun; 21(6):609-18, e21-2. PubMed ID: 19220754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.